VAXZEVRIA
2,5X10^8INF.U/0,5ML INJ SUS 10X5ML
| SÚKL code | 0250388 |
|---|---|
| Name of the product | VAXZEVRIA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | VAXZEVRIA |
| Supplement | 2,5X10^8INF.U/0,5ML INJ SUS 10X5ML |
| Strenght | 2,5X10^8INF.U/0,5ML |
| Pharmaceutical form | Suspension for injection |
| Package | 10X5ML |
| Route | Intramuscular use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | COVID-19 (CHADOX1-S) RECOMBINANT VACCINE (COVID-19 (CHADOX1-S) RECOMBINANT VACCINE) |
| ATC group | J07BX03 |
| ATC group name | VAKCÍNY PROTI COVID-19 |
Marketing authorisation information
| Registration Number | EU/1/21/1529/002 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | AstraZeneca AB, Södertälje |
| MA Holder country | ŠVÉDSKO |
cz